Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) have been given an average recommendation of “Hold” by the seventeen research firms that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and five have given a buy recommendation […]
Mawer Investment Management Ltd. trimmed its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 2.3% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,821,348 shares of the company’s stock after selling 43,344 shares during the period. Moderna makes […]
Privium Fund Management B.V. increased its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 43.6% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 43,861 shares of the company’s stock after acquiring an additional 13,310 shares during the period. Moderna makes up approximately 1.4% […]
Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) have been given a consensus rating of “Hold” by the seventeen ratings firms that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have assigned a buy rating to […]
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD boosted its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 9.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,858 shares of the company’s stock after […]